يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"Karason, Kristjan"', وقت الاستعلام: 0.65s تنقيح النتائج
  1. 1
  2. 2
    دورية أكاديمية

    المساهمون: HUS Heart and Lung Center, Kardiologian yksikkö, Helsinki University Hospital Area, HUSLAB, Department of Surgery, University of Helsinki

    وصف الملف: application/pdf

    العلاقة: The EVOLVD trial is an investigatorinitiated trial. Amgen provides the medicinal investigational products and a grant for the conduct of the trial. The sponsor has no role in the design or conduct of the trial, or in the collection and interpretation of data, or in the decision to publish. The authors take full responsibility for the integrity of the data.; Broch , K , Gude , E , Karason , K , Dellgren , GÖ , Radegran , G , Gjesdal , G , Gustafsson , F , Eiskjaer , H , Lommi , J , Pentikäinen , M , Lemström , K B , Andreassen , A K & Gullestad , L 2020 , ' Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients : Design of the randomized controlled EVOLVD trial ' , Clinical Transplantation , vol. 34 , no. 9 , 13984 . https://doi.org/10.1111/ctr.13984Test; ORCID: /0000-0001-6920-4093/work/82752716; 63be015f-e5b8-43eb-9146-93a3f8b16469; http://hdl.handle.net/10138/333734Test; 000556020400001

  3. 3
    دورية أكاديمية

    المصدر: Broch , K , Gude , E , Karason , K , Dellgren , G , Rådegran , G , Gjesdal , G , Gustafsson , F , Eiskjær , H , Lommi , J , Pentikäinen , M , Lemström , K B , Andreassen , A K & Gullestad , L 2020 , ' Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients : Design of the randomized controlled EVOLVD trial ' , Clinical Transplantation , vol. 34 , no. 9 , e13984 . https://doi.org/10.1111/ctr.13984Test

    وصف الملف: application/pdf

  4. 4
  5. 5
    دورية أكاديمية